Filter posts

Informed Perspectives: A Preview of the Personalized Medicine & Diagnostics Track

The Biotechnology Innovation Organization (BIO) has a long history of delivering impactful educational sessions about …

What We’ll Be Talking about at the BIO Spring IPCC Conference

It’s time once again for BIO’s Spring IPCC Conference! BIO’s biannual Intellectual Property Counsels Committee …

Emerging Themes in Personalized Medicine

The adoption of Personalized Medicine is being driven by the omnipresence of Next-Generation Sequencing (NGS), …

Integrating Personalized Medicine into Health Care: PMC/BIO Solutions Summit

While issues in science, regulation and reimbursement are still the focus of most stakeholders in …

NIH Director Francis Collins Opens Day Two at BIO International Convention

What happens when a hotel loses Francis Collins’ room reservation late on the eve before …

Making the Case for Personalized Medicine

Personalized medicine is the customization of healthcare. Already, a suite of molecular approaches is being …

Making the Case for Personalized Medicine

As lawmakers, industry, consumer groups and the general public debate the future of health care, …

Delivering on the Promise of Personalized Medicine

As sequencing moves out of the lab and into the clinic, a host of players …

Pharmaceuticals Play a Key Role in Value-Based Care

By Dan Leonard, President, National Pharmaceutical Council Public and private sector health care stakeholders have …

Mayo v. Prometheus: Thought Leaders Express Concern and Evaluate the Impact

The Mayo v. Prometheus event hosted at George Washington School of Law with the Biotechnology …